MRI and biopsy in prostate cancer are the hot topic in this number of International Brazilian Journal of Urology

Abstract

and USA, and as usual the editor ś comment highlights some of them. The editor in chief would like to highlight the following works:Dr. Andrade and collegues from Brazil, presented in page 237 (1) a nice systematic review about the outcomes of ablative therapy and radical treatment for prostate cancer and concluded that the biochemical recurrence and urinary continence outcomes of ablative therapy and radical treatment were similar. Ablative therapy appears to have a high rate of sexual potency.Dr. Lepine and collegues from Brazil, presented in page 250 (2) we can obseve an important sytematic review about the intraoperative Computed Tomography (ICT) for detection of residual stones in endourology procedures and concluded that the use of ICT scans during PCNL significantly increases success rates when compared to the standard fluoroscopy-guided detection of residual stones. Our findings also indicate decreased reintervention rates, with no statistically significant differences in complication rates.Dr. Gomes and collegues from Brazil performed in page 287 (3) an interesting study about theurinary tract symptoms in a prospective cohort of COVID-19 survivors and concluded that LUTS are highly prevalent and bothersome six months after hospitalization due to COVID-19. Assessment of LUTS may help ensure appropriate diagnosis and treatment in these patients.Dr. Paesano and collegues from Spain, performed in page 296 (4) a nice study about the effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies and concluded that this model had the potential to avoid 23.3% of prostate biopsies without missing additional csPCa cases. Mapping-targeted biopsies of the index lesion was highly effective for identifying clinically significant prostate cancer (csPCa) in fusion transperineal prostate biopsies. A developed predictive model successfully reduced the need for almost one quarter of biopsies without missing csPCa cases.Dr. Manfredi and collegues from Italy performed in page 309 (5) a study about the new technologies in BPH treatment. The authors shows the long term functional outcomes and surgical retreatment after thulium laser enucleation of prostate and concluded that ThuLEP is associated with optimal functional outcomes and a low frequency of